title: Update on NewLink's HyperAcute cancer immunotherapy products.
authors.forename: Eva M
authors.initials: EM
authors.lastname: Riedmann
mesh_terms: D019496:Cancer Vaccines / Q000008:administration & dosage / Q000276:immunology*; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D008175:Lung Neoplasms / Q000628:therapy*; D010190:Pancreatic Neoplasms / Q000628:therapy*; D016896:Treatment Outcome
chemical_list: D019496:Cancer Vaccines